deltatrials
Terminated PHASE2 INTERVENTIONAL 2-arm NCT01698281

Phase 2 Trial of AEZS-108 in Chemotherapy Refractory in Triple Negative Breast Cancer

A Randomized Phase 2 Trial of AEZS-108 in Chemotherapy Refractory Triple Negative, LHRH-positive Metastatic Breast Cancer.

Sponsor: AEterna Zentaris

Conditions Breast Cancer
Interventions AEZS-108 Dexamethasone SCCC
Updated 8 times since 2017 Last updated: Feb 20, 2018 Started: Dec 31, 2012 Primary completion: Aug 31, 2014 Completion: Oct 31, 2014
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

Poor recruitment

Other terminated trials from AEterna Zentaris

See all terminations from AEterna Zentaris

Other Breast Cancer trials with similar outcome

Browse all Breast Cancer trials

Listed as NCT01698281, this PHASE2 trial focuses on Breast Cancer and remains terminated or withdrawn. Sponsored by AEterna Zentaris, it has been updated 8 times since 2012, reflecting limited change activity. This study contributes to the evolving evidence base for cancer treatment protocols.

Status Flow

~Jan 2017 – ~Feb 2017 · 31 days · monthly snapshotTerminated~Feb 2017 – ~Mar 2018 · 13 months · monthly snapshotTerminated~Mar 2018 – ~Jun 2018 · 3 months · monthly snapshotTerminated~Jun 2018 – ~Jan 2021 · 31 months · monthly snapshotTerminated~Jan 2021 – ~Apr 2022 · 15 months · monthly snapshotTerminated~Apr 2022 – ~Jul 2024 · 27 months · monthly snapshotTerminated~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotTerminated~Sep 2024 – present · 22 months · monthly snapshotTerminated

Change History

8 versions recorded

  1. Sep 2024 — Present [monthly]

    Terminated PHASE2

  2. Jul 2024 — Sep 2024 [monthly]

    Terminated PHASE2

  3. Apr 2022 — Jul 2024 [monthly]

    Terminated PHASE2

  4. Jan 2021 — Apr 2022 [monthly]

    Terminated PHASE2

  5. Jun 2018 — Jan 2021 [monthly]

    Terminated PHASE2

▶ Show 3 earlier versions

  1. Mar 2018 — Jun 2018 [monthly]

    Terminated PHASE2

  2. Feb 2017 — Mar 2018 [monthly]

    Terminated PHASE2

  3. Jan 2017 — Feb 2017 [monthly]

    Terminated PHASE2

    First recorded

Dec 2012

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • AEterna Zentaris
Data source: AEterna Zentaris

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations